News for Healthier Living

Post-Surgery Strategy Shows Promise in Delaying Liver Cancer Recurrence

Postoperative recurrence remains the main reason many liver cancer patients fail to achieve long-term survival after surgery. A new prospective multicenter study shows that combining a targeted systemic therapy with postoperative transarterial chemoembolization can significantly delay tumor recurrence in patients at high risk. The dual approach integrates systemic and locoregional control to suppress residual disease following curative resection. Patients receiving the combined therapy experienced a markedly longer period without cancer recurrence than those receiving standard treatment alone, while maintaining a manageable safety profile. These findings suggest that intensifying postoperative treatment may offer a practical and effective strategy to improve outcomes for patients most vulnerable to early relapse.

January 21, 2026


January 22 2026

January 21 2026

January 20 2026

January 19 2026

January 18 2026

January 17 2026

January 16 2026

January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026